Former FBI trainee charged with insider trading scheme ahead of Merck-Pandion buyout
Working from home presents some unique challenges. Just ask a lawyer who represented Merck during its $1.85 billion Pandion takeover.
A former FBI trainee has been charged with insider trading over profits he made from buying Pandion stock based on private information about the Merck acquisition — which he allegedly learned while working from home with a “romantic partner,” who also happened to be an associate at a law firm representing Merck.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.